As of 2026-04-06, the Relative Valuation of Gennex Laboratories Ltd (531739.BO) is 12.02 INR. This relative valuation is based on P/E multiples. With the latest stock price at 9.41 INR, the upside of Gennex Laboratories Ltd based on Relative Valuation is 27.8%.
The range of the Relative Valuation is 9.32 - 16.27 INR.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 20.2x | 16.8x |
| Forward P/E multiples | 11.1x - 14.6x | 12.4x |
| Fair Price | 9.32 - 16.27 | 12.02 |
| Upside | -1.0% - 72.9% | 27.8% |
| Date | P/E |
| 2026-04-02 | 11.68 |
| 2026-04-01 | 10.62 |
| 2026-03-30 | 8.83 |
| 2026-03-27 | 10.03 |
| 2026-03-25 | 10.50 |
| 2026-03-24 | 10.62 |
| 2026-03-23 | 10.43 |
| 2026-03-20 | 11.67 |
| 2026-03-19 | 11.66 |
| 2026-03-18 | 11.78 |
| 2026-03-17 | 11.78 |
| 2026-03-16 | 11.53 |
| 2026-03-13 | 12.27 |
| 2026-03-12 | 12.40 |
| 2026-03-11 | 12.65 |
| 2026-03-10 | 12.42 |
| 2026-03-09 | 12.91 |
| 2026-03-06 | 13.64 |
| 2026-03-05 | 14.23 |
| 2026-03-04 | 13.40 |
| 2026-03-02 | 13.66 |
| 2026-02-27 | 14.03 |
| 2026-02-26 | 13.78 |
| 2026-02-25 | 13.91 |
| 2026-02-24 | 14.40 |
| 2026-02-23 | 14.63 |
| 2026-02-20 | 14.48 |
| 2026-02-19 | 14.90 |
| 2026-02-18 | 14.70 |
| 2026-02-17 | 14.75 |
| 2026-02-16 | 14.76 |
| 2026-02-13 | 15.36 |
| 2026-02-12 | 15.15 |
| 2026-02-11 | 15.56 |
| 2026-02-10 | 15.63 |
| 2026-02-09 | 15.45 |
| 2026-02-06 | 15.09 |
| 2026-02-05 | 15.26 |
| 2026-02-04 | 15.48 |
| 2026-02-03 | 15.31 |
| 2026-02-02 | 15.32 |
| 2026-02-01 | 15.73 |
| 2026-01-30 | 15.25 |
| 2026-01-29 | 15.15 |
| 2026-01-28 | 15.04 |
| 2026-01-27 | 14.90 |
| 2026-01-23 | 15.77 |
| 2026-01-22 | 15.79 |
| 2026-01-21 | 16.34 |
| 2026-01-20 | 16.14 |